{"id":"W4281382713","doi":"10.1111/bjd.21677","title":"Biomarkers of systemic treatment response in people with psoriasis: a scoping review","year":2022,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":42,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Medical Research Council; Banting and Best Diabetes Centre, University of Toronto; Canadian Institutes of Health Research; Innovative Medicines Initiative; Astellas Pharma; Novo Nordisk; National Institute for Health and Care Research; Department of Medicine, University of Toronto; Psoriasis Association; Department of Health and Social Care; European Commission; Sanofi; Kidney Foundation of Canada; Merck Canada; University of Toronto; European Federation of Pharmaceutical Industries and Associations; AstraZeneca; Eli Lilly and Company; King's College London; Gilead Sciences; Vifor Pharma; Heart and Stroke Foundation of Canada; Amgen","keywords":"Psoriasis; Medicine; Intensive care medicine; Dermatology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007487162,0.0004600458,0.00493353,0.0006686396,0.0001079644,0.00001181819,0.0004587168,0.0004213636,0.0004923352],"category_scores_gemma":[0.0002272608,0.000391122,0.0008269672,0.0006473108,0.0001275962,0.00008564324,0.00007323921,0.0004216133,0.00002292865],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003801759,"about_ca_system_score_gemma":0.002286986,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001191522,"about_ca_topic_score_gemma":0.0001966387,"domain_scores_codex":[0.9925132,0.004403498,0.002203039,0.00035329,0.00009752526,0.0004294331],"domain_scores_gemma":[0.9958003,0.001261641,0.002471988,0.0003274397,0.00009211403,0.00004656032],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.001398341,0.0004157775,0.0001936633,0.05001097,0.003460422,0.008052425,0.0001562939,3.966163e-7,0.000009625703,0.000003252152,0.0005317992,0.9357671],"study_design_scores_gemma":[0.002989413,0.0006886319,0.00004523708,0.4393085,0.003617292,0.4283559,0.0001297822,1.496957e-8,0.00002107534,9.501931e-7,0.1245595,0.0002837673],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002541265,0.9951535,0.000004604295,0.00004252883,0.0007178668,0.001344692,0.0001309769,0.00001308563,0.000051519],"genre_scores_gemma":[0.0007735321,0.9986377,0.00005145175,0.00002074259,0.00001987623,0.0002615003,0.0001176325,0.00005125778,0.00006629602],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9354833,"threshold_uncertainty_score":0.9998541,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03199486558586388,"score_gpt":0.2962376370307939,"score_spread":0.26424277144493,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}